Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 301–400 of 1,004
Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 79
“Although the initial microglial activation aims at clearance of Aβ plaques and might exert a neuroprotective effect, its continuous triggering and the inefficacy in the clearing process might lead to a vicious cycle of sustained chronic inflammation, with an ultimately neurotoxic effect [112].”
BackgroundALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation
Bai, D., Du, J., Bu, X., Cao, W., Sun, T., Zhao, J., Zhao, Y., & Lu, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1997051 · Cited by 75
“tory syndrome, gout, osteoarthritis, Alzheimer’s disease, Type 2 diabetes, atherosclerosis, and cancer [2,41].”
Wang, Z., Hu, W., Lu, C., Ma, Z., Jiang, S., Gu, C., Acuña-Castroviejo, D., & Yang, Y. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311916 · Cited by 77
Brain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease
Brioschi, S., Zhou, Y., & Colonna, M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900821 · Cited by 68
Błaszczyk, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010543 · Cited by 86
Alam, M., Rashid, S., Fatima, K., Adnan, M., Shafie, A., Akhtar, S., Ganie, A. H., Eldin, S. M., Islam, A., Khan, I., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114710 · Cited by 78
RetractedZveik, O., Rechtman, A., Ganz, T., & Vaknin-Dembinsky, A. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00742-8 · Cited by 67
Yin, M., Chen, Y., Zheng, H., Pu, T., Marshall, C., Wu, T., & Xiao, M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.034 · Cited by 70
Effects of sulforaphane in the central nervous system
Huang, C., Wu, J., Chen, D., Jin, J., Wu, Y. H., & Chen, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.010 · Cited by 77
Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
Kantarci, A., Tognoni, C. M., Yaghmoor, W., Marghalani, A., Stephens, D., Ahn, J.-Y., Carreras, I., & Dedeoglu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75517-4 · Cited by 66
Extracellular vesicles in the treatment of neurological disorders
Reed, S. L., & Escayg, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105445 · Cited by 75
“Also, aberrant immune activation or dysregulation in many NDs is associated with increased neuronal damage (Heneka et al., 2014; Stephenson et al., 2018).”
BackgroundCampos, J. C., Wu, Z., Rudich, P. D., Soo, S. K., Mistry, M., Ferreira, J. C. B., Blackwell, T. K., & Raamsdonk, J. M. V. (2021) · EMBO Reports · doi:10.15252/embr.202152964 · Cited by 79
“Although OP50 bacteria, which are typically used for C. elegans maintenance and lifespan assays, are considered to be non-pathogenic, it can have detrimental effects on lifespan through proliferation in the pharynx and intestine (Gems & Riddle, 2000; Garigan et al , 2002).”
Liu, D., Zhang, H., Wang, Y., Liu, W., Yin, G., Wang, D., Li, J., Shi, T., & Wang, Z. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114044 · Cited by 68
Gereñu, G., Liu, K., Chojnacki, J. E., Saathoff, J. M., Martínez‐Martín, P., Perry, G. L., Zhu, X., Lee, H., & Zhang, S. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00082 · Cited by 70
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
Baldacci, F., Lista, S., Palermo, G., Giorgi, F. S., Vergallo, A., & Hampel, H. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1628643 · Cited by 67
Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
Ruffini, N., Klingenberg, S., Schweiger, S., & Gerber, S. (2020) · Cells · doi:10.3390/cells9122642 · Cited by 75
Casati, M., Ferri, E., Gussago, C., Mazzola, P., Abbate, C., Bellelli, G., Mari, D., Cesari, M., & Arosio, B. (2018) · European Journal of Neurology · doi:10.1111/ene.13583 · Cited by 66
“Neuroinflammation is a common feature of neurodegenerative diseases [12].”
BackgroundGlial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?
Abati, E., Citterio, G., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104870 · Cited by 75
Garcez, M. L., Tan, V. X., Heng, B., & Guillemin, G. J. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920978404 · Cited by 69
“01) significantly attenuated KYN/TRP ratio induced by LPS, which returned to non-LPS control levels (Figure 4A; 2-way ANOVA, interaction [F (4, 10) = 5.”
BackgroundInfluentialRedox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 73
de Matos, A. M., de Macedo, M. P., & Rauter, A. P. (2018) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 66
Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
Li, J., Zhuang, L., Luo, X., Liang, J., Sun, E., & He, Y. (2020) · Experimental Brain Research · doi:10.1007/s00221-020-05916-6 · Cited by 69
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
van der Ende, E. L., Meeter, L. H., Stingl, C., van Rooij, J. G. J., Stoop, M. P., Nijholt, D. A. T., Sanchez‐Valle, R., Graff, C., Öijerstedt, L., Grossman, M., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.745 · Cited by 65
Yang, Y., He, Z., Xing, Z., Zuo, Z., Yuan, L., Wu, Y., Jiang, M. H., Qi, F., & Yao, Z. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01741-4 · Cited by 74
Xie, J., Gorlé, N., Vandendriessche, C., Van Imschoot, G., Van Wonterghem, E., Van Cauwenberghe, C., Parthoens, E., Van Hamme, E., Lippens, S., Van Hoecke, L., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01253-z · Cited by 65
The role of the immunoproteasome in interferon-γ-mediated microglial activation
Moritz, K. E., McCormack, N. M., Abera, M. B., Viollet, C., Yauger, Y. J., Sukumar, G., Dalgard, C. L., & Burnett, B. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-09715-y · Cited by 64
HHV-6A infection induces amyloid-beta expression and activation of microglial cells
Bortolotti, D., Gentili, V., Rotola, A., Caselli, E., & Rizzo, R. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0552-6 · Cited by 70
Kaewmool, C., Udomruk, S., Phitak, T., Pothacharoen, P., & Kongtawelert, P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00102-1 · Cited by 67
He, X., Xu, J., Li, G., Li, M., Li, L., Pei, Z., Zhang, L., & Hu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03072-x · Cited by 70
Gong, Y., Huang, A., Guo, X., Zhi, J., Chen, X., Zhu, X., Xia, Y., Liu, J., Xu, Y., & Qin, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129345 · Cited by 64
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 74
“Aberrant proinflammatory signaling in the CNS because of the presence of persistent insult can disrupt a myriad of processes leading to excessive synaptic pruning, synaptic dysfunction, reduced blood- brain barrier integrity, and neuronal death (Heneka et al., 2014; Lyman et al., 2014).”
BackgroundNeuroinflammation in neurodegeneration via microbial infections
Tran, V. T. A., Lee, L. P., & Cho, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907804 · Cited by 81
“Typically, their neuroinflammation has protective roles; however, certain pathogens trigger detrimental proinflammation, which could result in synaptic damage, cell loss, and entanglement of neurogenesis (25).”
BackgroundNeuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia
Marques, C., Held, A., Dorfman, K., Sung, J., Song, C., Kavuturu, A. S., Aguilar, C., Russo, T., Oakley, D. H., Albers, M. W., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02688-z · Cited by 72
“Neuroinflammation, characterized largely by the initiation and propagation of innate immune signaling, leads to the activation of microglia and astrocytes within the central nervous system and plays an increasingly appreciated role in neurodegenerative diseases [36].”
BackgroundAlkhazaali-Ali, Z., Negah, S. S., Boroumand, A. R., & Tavakol‐Afshari, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116899 · Cited by 76
Merighi, S., Bencivenni, S., Vincenzi, F., Varani, K., Borea, P. A., & Gessi, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.024 · Cited by 70
“This implies a change of morphology and functions, cell proliferation, increase in the production of a variety of cytotoxic mediators contributing to the damage of surrounding healthy neurons [31,32].”
BackgroundA unique array of neuroprotective effects of pyruvate in neuropathology
Zilberter, Y., Gubkina, O., & Ivanov, A. I. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00017 · Cited by 64
“…energy metabolism, pyruvate, neurodegeneration, oxidative stress, PARP-1, NAD, neuroinflammation The three common signature characteristics of many neurological diseases are brain hypometabolism, oxidative stress, and neuroinflammation (Melo et al., 2011; Cai et al., 2012; Heneka et al., 2014).”
BackgroundBohm, C., Chen, F., Sevalle, J., Qamar, S., Dodd, R., Li, Y., Schmitt-Ulms, G., Fraser, P. E., & St George-Hyslop, P. H. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.016 · Cited by 63
“…misfolding protein aggregates such as amyloid oligomers and fibrils is known to activate innate immune responses via complement pathways, including complement receptor (CR1), and microglial signalling elements, such as TREM2 (see review) (Heneka et al., 2014; Schwartz and Shechter, 2010).”
BackgroundMicroglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
Anwar, S., Pons, V., & Rivest, S. (2020) · Cells · doi:10.3390/cells9071595 · Cited by 63
“Microglia actively monitor and scan the cerebral microenvironment by continually extending and retracting ramified processes for molecular indicators of damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs) [8,9] (Figure 1).”
BackgroundSources and triggers of oxidative damage in neurodegeneration
Angelova, P. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.003 · Cited by 72
Nebeling, F. C., Poll, S., Justus, L. C., Mittag, M., Steffen, J., Keppler, K., & Fuhrmann, M. (2023) · eLife · doi:10.7554/elife.83176 · Cited by 70
“While microglia have been linked to a number of neurodegenerative diseases such as Alzheimer’s disease (Heneka et al., 2014; Ransohoff, 2016), little is known about their physiological function under healthy conditions (Tay et al.”
BackgroundDisulfiram blocks inflammatory TLR4 signaling by targeting MD-2
Bai, Y., Min, R., Chen, P., Mei, S., Deng, F., Zheng, Z., Jiang, C., Miao, R., Wu, Z., Zhang, P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306399120 · Cited by 65
“Recent studies found that TLR4-mediated inflammation is involved in the pathogenesis of Parkinson’s disease (PD), a neurodegenerative disease that pnas.org destroys dopaminergic neurons in the brain (19, 20).”
BackgroundFerroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease
Wang, Q., Sun, J., Chen, T., Song, S., Hou, Y., Feng, L., Fan, C., & Li, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00343 · Cited by 69
Liu, H., Wang, J., Wang, J., Wang, P., & Xue, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.035 · Cited by 69
“…microglia is able to clear Aβ or Aβ-Aβ receptor complexes and subsequently reduce the toxicity of Aβ, but the overactivated microglia clustering to neuritic plaques can persistently produce neurotoxic factors which may lead to further damage in the brain (Block et al., 2007; Heneka et al., 2014).”
Le Page, A., Bourgade, K., Lamoureux, J., Frost, E., Pawelec, G., Larbi, A., Witkowski, J. M., Dupuis, G., & Fülöp, T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143054 · Cited by 63
Lian, H., Roy, E., & Zheng, H. (2016) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1988 · Cited by 63
“Upon stimulation, microglia present complicated inflammatory responses including altered gene expression and morphological changes (Heneka et al., 2014; Cunningham, 2013).”
BackgroundJeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx065 · Cited by 62
“However, deregulated inflammasome activation has been increasingly implicated in the pathogenesis of metabolic or neurodegenerative disorders (Henao-Mejia et al., 2014; Heneka et al., 2014).”
BackgroundMapping neuroinflammation in frontotemporal dementia with molecular PET imaging
Zhang, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0236-5 · Cited by 62
“There is evidence that sustained exposure to bacterial lipopolysaccharide (LPS) or other pro-inflammatory mediators restricts microglial phagocytosis of protein aggregation and suppresses axonal transportation [10].”
BackgroundResultInfluentialAgeing neuroinflammation and neurodegeneration
Ward, R. J. (2015) · Frontiers in Bioscience · doi:10.2741/s433 · Cited by 62
Vida, C., Martinez de Toda, I., Garrido, A., Carro, E., Molina, J. A., & De la Fuente, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01974 · Cited by 62
Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
Shukla, A. K., Spurrier, J. M., Kuzina, I., & Giniger, E. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.025 · Cited by 64
“Neuroinflammation is an important component of many NDs, including Alzheimer disease (AD), frontotemporal dementia (FTD), Parkinson disease (PD), and others (Gjoneska et al., 2015; Heneka et al., 2014; Holmes et al., 2009; Richards et al., 2016; Zhang, 2015).”
Iron–sulfur clusters as inhibitors and catalysts of viral replication
Ebrahimi, K. H., Ciofi‐Baffoni, S., Hagedoorn, P., Nicolet, Y., Brun, N. E. L., Hagen, W. R., & Armstrong, F. A. (2022) · Nature Chemistry · doi:10.1038/s41557-021-00882-0 · Cited by 70
Li, Y., Sibon, O. C. M., & Dijkers, P. F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1278-2 · Cited by 70
“Besides this, another characteristic in most, if not all neurodegenerative diseases associated with protein aggregation is the activation of astrocytes [3].”
BackgroundKell, D. B., Potgieter, M., & Pretorius, E. (2015) · F1000Research · doi:10.12688/f1000research.6709.2 · Cited by 67
Inflammation as the Potential Basis in Depression
Maeng, S., & Hong, H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938226.113 · Cited by 71
“Reactive astrocytes and microglia are known to mediate the innate immune responses in the brain [27].”
BackgroundNeuroprotective effects of geniposide on Alzheimer’s disease pathology
Liu, W., Li, G., Hölscher, C., & Li, L. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0005 · Cited by 67
Landlinger, C., Oberleitner, L., Gruber, P., Noiges, B., Yatsyk, K., Santic, R., Mandler, M., & Staffler, G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0369-6 · Cited by 68
“Inflammatory processes in AD are primarily triggered by the up-regulation of the complement system in response to misfolded and aggregated proteins or mislocalized nucleic acids and reactive microglia [10, 16, 17].”
BackgroundGramlich, O. W., Ding, Q. J., Zhu, W., Cook, A. C., Anderson, M. G., & Kuehn, M. H. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0234-y · Cited by 69
“One important feature that the glaucomatous retina shares with many other neurodegenerative diseases is the accumulation of components of the immune system that occurs subsequent to the onset of the disease [21, 49].”
BackgroundMesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases
Chen, X., Wang, S., & Cao, W. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.06.006 · Cited by 66
“It seems clearly that neuroinflmmatory processes mediated byβ-amyloid (Aβ) plaques-induced activationof proinflammatory microglial cells contribute to AD pathogenesis[86].”
BackgroundDibello, V., Custodero, C., Cavalcanti, R., Lafornara, D., Dibello, A., Lozupone, M., Daniele, A., Pilotto, A., Panza, F., & Solfrizzi, V. (2024) · GeroScience · doi:10.1007/s11357-024-01243-8 · Cited by 79
“Furthermore, chronic inflammation caused by periodontal disease has been linked to the formation of amyloid-β plaques in the brain [81], which are a hallmark of AD.”
Gargouri, B., Bhatia, H. S., Bouchard, M., Fiebich, B. L., & Fetoui, H. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.05.020 · Cited by 61
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Lima, M. N., Barbosa‐Silva, M. C., & Maron‐Gutierrez, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.878987 · Cited by 71
“Once confronted with stimuli, microglia induce and modulate a broad spectrum of molecular and cellular responses in an attempt to eradicate the pathogen (Heneka et al., 2014; Widmann and Heneka, 2014).”
BackgroundTiwari, V., Prajapati, B., Asare, Y., Damkou, A., Ji, H., Liu, L., Naser, N., Gouna, G., Leszczyńska, K. B., Mieczkowski, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.001 · Cited by 53
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Hyde, V. R., Zhou, C., y Fernández, J. R. M., Chatterjee, K., Ramakrishna, P., Lin, A., Fisher, G. W., Celiker, O. T., Caldwell, J., Bender, O., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115109 · Cited by 66
Toll-Like Receptor 4 Deficiency Impairs Motor Coordination
Zhu, J.-W., Li, Y.-F., Wang, Z.-T., Jia, W.-Q., & Xu, R.-X. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00033 · Cited by 57
Genetic models of C9orf72: what is toxic?
Moens, T. G., Partridge, L., & Isaacs, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.006 · Cited by 64
“These findings are particularly interesting given the increasing evidence supporting a role for the immune system in a wide range of neurodegenerative diseases[38].”
BackgroundTDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes
LaRocca, T. J., Mariani, A., Watkins, L. R., & Link, C. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104514 · Cited by 63
Apoptotic neurodegeneration in whitefly promotes the spread of TYLCV
Wang, S., Guo, H., Ge, F., & Sun, Y. (2020) · eLife · doi:10.7554/elife.56168 · Cited by 61
“Pathogen infection triggers the innate immune response in the CNS of Drosophila resulting in inflammatory signaling and neurodegeneration (Cao et al., 2013; Delorme-Axford and Klionsky, 2019; Liu et al., 2018).”
BackgroundInfluentialThe involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 61
Hajinejad, M., Ghaddaripouri, M., Dabzadeh, M., Forouzanfar, F., & Negah, S. S. (2020) · BioMed Research International · doi:10.1155/2020/1034325 · Cited by 62
“CA Permanent cerebral ischemia Mouse 50mg/kg Suppress the activation of TLR4, TRAF6, and NF-κB signaling Attenuate levels of TNF-α, IL-1β, CCL2, and ELAM-1 Antiinflammatory effect [31]”
MethodKumari, S., Dhapola, R., Sharma, P., Singh, S. K., & HariKrishnaReddy, D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102098 · Cited by 58
Extracellular Vesicles as Mediators of Neuroinflammation in Intercellular and Inter-Organ Crosstalk
Cabrera‐Pastor, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137041 · Cited by 67
“Neuroinflammation, characterized by immune responses within the central nervous system (CNS), stands as a central player in various neurological disorders, such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and hepatic encephalopathy [1,2].”
BackgroundChowdhury, A. A., Gawali, N. B., Shinde, P., Munshi, R., & Juvekar, A. R. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.018 · Cited by 60
Gargouri, B., Yousif, N. M., Attaai, A., Bouchard, M., Chtourou, Y., Fiebich, B. L., & Fetoui, H. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.004 · Cited by 62
Zhong, X., Qiang, Y., Wang, L., Zhang, Y., Li, J., Feng, J., Cheng, W., Tan, L., & Yu, J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02683-0 · Cited by 55
“The components of the innate immune response mainly include monocytes, macrophages, neutrophils, dendritic cells, mast cells, and natural killer cells [6, 7].”
BackgroundAlzheimer´s Disease associated with Psychiatric Comorbidities
Garcez, M. L., Falchetti, A. C. B., Mina, F., & Budni, J. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140716 · Cited by 67
Steiner, N., Balez, R., Karunaweera, N., Lind, J. M., Münch, G. W., & Ooi, L. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.013 · Cited by 59
“…increasing evidence suggests that innate M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 3 | P a g e immune activation is a major component of age-related neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease (for recent reviews see (Heneka et al., 2014, Norden et al., 2014)).”
Kobayashi, M., Konishi, H., Takai, T., & Kiyama, H. (2015) · Glia · doi:10.1002/glia.22802 · Cited by 55
“Since M1-polarized pro-inflammatory microglia are considered to be deleterious to injured neurons (David and Kroner, 2011; Heneka et al., 2014), it is likely that neuronal damages by microglia are diminished in DAP12-deficient mice.”
BackgroundHistone deacetylase 6 negatively regulates NLRP3 inflammasome activation
Hwang, I., Lee, E., Jeon, S., & Yu, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.033 · Cited by 55
Hofmann-Apitius, M., Ball, G., Gebel, S., Bagewadi, S., De Bono, B., Schneider, R., Page, M., Kodamullil, A., Younesi, E., Ebeling, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226148 · Cited by 55
“, the role of sterile inflammation in the brain [14]; or the debate on prion-like spreading of the disease [15]) indicate the complexity and diversity of routes that lead to the dramatic changes that we observe in later stages of dementias.”
BackgroundAhmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., AL-Ayadhi, L. Y., & Attia, S. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.034 · Cited by 60
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation
Grasselli, C., Ferrari, D., Zalfa, C., Soncini, M., Mazzoccoli, G., Facchini, F. A., Marongiu, L., Granucci, F., Copetti, M., Vescovi, A. L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0139-8 · Cited by 62
Garcez, M. L., Mina, F., Bellettini‐Santos, T., da Luz, A. P., Schiavo, G. L., Macieski, J. M. C., Medeiros, E. B., Marques, A. O., Magnus, N. Q., & Budni, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1211-9 · Cited by 56
Yang, X., Sun, J., Kim, T. J., Kim, Y. J., Ko, S., Kim, C. K., Jia, X., & Yoon, B. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.013 · Cited by 60
“The inflammasome plays a key role in the innate immune response in the central nervous system (CNS) diseases (Heneka et al., 2017).”
CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
Henjum, K., Quist-Paulsen, E., Zetterberg, H., Blennow, K., Nilsson, L. N. G., & Watne, L. O. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1331-1 · Cited by 55
Canet-Pons, J., Şen, N.-E., Arsović, A., Almaguer-Mederos, L. E., Halbach, M. V., Key, J., Döring, C., Kerksiek, A., Picchiarelli, G., Cassel, R., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105289 · Cited by 54
Aslanidis, A., Karlstetter, M., Scholz, R., Fauser, S., Neumann, H., Fried, C., Pietsch, M., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0296-6 · Cited by 54
“We observed an increased phagocytic uptake of apoptotic photoreceptor fragments by AMWAP-treated microglia, which was independent of further LPS stimulation as apoptotic cells per se represent an activating stimulus for microglia [8].”
BackgroundLópez‐González, I., Viana, R., Sanz, P., & Ferrer, I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9884-4 · Cited by 54
Zou, Z., Chen, J., Feng, H.-F., Cheng, Y., Wang, H., Zhou, Z., Guo, H., Zheng, W., & Xu, J. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239608 · Cited by 58
Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease
Song, M., Zhao, X., & Song, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02248-y · Cited by 60
van Dijk, B. J., Vergouwen, M. D. I., Kelfkens, M. M., Rinkel, G. J. E., & Hol, E. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.013 · Cited by 55
“These cytokines contribute to apoptosis in neurons [43].”
BackgroundCatorce, M. N., Acero, G., Pedraza‐Chaverrí, J., Fragoso, G., Govezensky, T., & Gevorkian, G. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.008 · Cited by 57
“Brains from patients with neurodegenerative diseases are characterized bymarked astrocytosis, activation of microglia and elevated levels of pro-inflammatory cytokines (Serrano-Pozo et al., 2011; McGeer and McGeer, 2013; Heneka et al., 2014).”
BackgroundThe pathogenesis of bornaviral diseases in mammals
Tizard, I. R., Ball, J. M., Stoica, G., & Payne, S. (2016) · Animal Health Research Reviews · doi:10.1017/s1466252316000062 · Cited by 54
“mainly derived from T cells, they may also be produced by microglia (Heneka et al., 2014).”
InfluentialTLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation
Park, S.-H., Shin, H., Shah, M., Cho, H.-Y., Anwar, M. A., Achek, A., Kwon, H., Byugsung, L., Yoo, T. H., & Choi, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.023 · Cited by 56
Jiang, L., Li, X., Mortadza, S. A. S., Lovatt, M., & Yang, W. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.002 · Cited by 55
Lv, R., Du, L., Liu, X., Zhou, F., Zhang, Z., & Zhang, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.006 · Cited by 57
Li, S., Hua, X., Zheng, M., Wu, J., Ma, Z., Xing, X., Ma, J., Zhang, J., Shan, C., & Xu, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113854 · Cited by 53
Translational Relevance of Swine Models of Spinal Cord Injury
Schomberg, D. T., Miranpuri, G. S., Chopra, A., Patel, K., Meudt, J. J., Téllez, A., Resnick, D. K., & Shanmuganayagam, D. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4567 · Cited by 56
“89 Microglia and macrophages, especially M2 macrophages, do have beneficial roles after SCI, such as inflammation reduction and matrix rebuilding.”
Arifuzzaman, S., Das, A., Kim, S. H., Yoon, T., Lee, Y. S., Jung, K. H., & Chai, Y. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.016 · Cited by 56
“Persistent microglial activation has been implicated in the pathogenesis of neuroinflammation and several neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Multiple sclerosis (MS) [6].”
BackgroundSynaptoimmunology - roles in health and disease
Nisticò, R., Salter, E., Nicolas, C., Feligioni, M., Mango, D., Bortolotto, Z. A., Gressens, P., Collingridge, G. L., & Peineau, S. (2017) · Molecular Brain · doi:10.1186/s13041-017-0308-9 · Cited by 52
“Astrocytes and adjacent neurons are also activated in parallel to this cascade leading to further factor release [39] (Fig.”
BackgroundMicroglia in Neurodegenerative Disorders
Tejera, D., & Heneka, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_5 · Cited by 58
Self-citation
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.